This MRFR Market Perspective Examines the Historical Trends and Current Scenario of the “Global Women Healthcare Market” to Deliver a Highly Pertinent Growth Forecast. And Registering 5.04% CAGR Along with Top Companies and Mega Trends.
Women Healthcare Market- Highlights Growth
According to Market Research Future (MRFR), the global women healthcare market is poised to garner exponential accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register over 5.04% CAGR throughout the forecast period (2017-2023).
Factors increasing the market demand include the lack of access to family planning programs, unwanted pregnancies, unsafe abortions injuries associated with abortions, complications about the frequent risky pregnancies, unavailability of follow-up care, sexually transmitted diseases infections, and other psychological problems related to women health.
Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/3121
Chronic malnutrition among girls women in the dominating male society and gender-biased systems are equally affecting women’s health, workplace, economic conditions, and sense of wellbeing. Simultaneously, the growing number of working women, especially in developing countries and the increasing awareness towards the advantages of women’s care, is propelling the market growth.
However, factors like unmet medical needs are anticipated to restrict the market growth. Nevertheless, technological advancements transpired in healthcare are expected to foster market growth.
Global Women Healthcare Market - Competitive Analysis
Fiercely competitive, the global Women Healthcare Market appears to be fragmented with the presence of several well-established as well as small players. These players incorporate strategic initiatives such as collaboration, acquisition, expansion, strategic partnership, and technology launch. Leading players are investing substantially in RD and clinical trials to develop effective drugs.
Key players leading the global women healthcare market include Amgen (California), Allergan plc. (Ireland), Bayer AG (Germany), Eli Lilly Company (US), Becton Dickinson and Company (US), Merck Co., Inc., (US), Teva Pharmaceuticals (Israel), and Pfizer Inc., (US), among others.
Industry/Innovation/ Related News:
August 26, 2019 ---- Amgen Inc. (the US), a multinational biopharmaceutical company announced that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers Squibb Company to acquire worldwide rights to Otezla and certain related assets and liabilities. Worldwide rights align with Amgen’s international presence and global expansion objectives.
Otezla (apremilast) is the only oral, non-biologic treatment for psoriasis and psoriatic arthritis. Amgen believes that the acquisition of Otezla can offer many benefits, such as Support of increased RD investment in 2020 to advance Amgen’s innovative pipeline of first-in-class molecules. Further, the partnership would also enable intellectual property exclusivity through at least 2028 in the US without interrupting deployment of Amgen’s capital allocation priorities.
Global Women Healthcare Market – Segments
The report is segmented into four market dynamics to widen the scope of understanding,
By Indication: Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer, and others.
By Diagnosis Treatment: Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, and others) and Treatment (Therapeutics, surgeries, and others)
By End-users: Hospitals Clinics, Gynecology Centers, and Research Institutes, among others.
By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.
Women Healthcare Market - Regional Analysis
North America leads the global women healthcare market, due to the increasing initiatives promoting women’s health and wellness. Additionally, the presence of well-developed healthcare infrastructure and leading players is supporting the regional market growth. Also, increasing emphasis on diagnosis and continuous monitoring of diseases associated with women, especially propel the growth of the regional market.
Furthermore, the high prevalence of various chronic diseases among women and the funding support from the companies, private organization, and government associations to improve women healthcare in the region drive the growth of the regional market.
Browse Complete 130 Pages Premium Research Report Enabled with 129 Respective Tables and Figures At https://www.marketresearchfuture.com/reports/women-healthcare-market-3121
The women healthcare market in the European region takes the second leading position. The resurging economy plays an important role in supporting the growth of the regional market, availing the best possible healthcare and increasing the per capita healthcare expenditures specially designed for women. Besides, government support that encourages the players to develop high-quality technologies for women’s health and wellness and favorable reimbursement policies are fostering the growth in the regional market.
The Asia Pacific women healthcare market is rapidly emerging as a profitable market globally. The prevalence of chronic diseases among women populaces is a key driving force behind the regional market growth. Moreover, factors such as the proliferating healthcare sector and spreading awareness among individuals towards women’s health and wellness and the availability of various care units drive the growth of the market in the region.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312